Nomura Asset Management Co. Ltd. Reduces Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Nomura Asset Management Co. Ltd. decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 57,635 shares of the company's stock after selling 763 shares during the quarter. Nomura Asset Management Co. Ltd.'s holdings in HCA Healthcare were worth $17,299,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $39,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC bought a new position in HCA Healthcare in the 4th quarter valued at $36,000. Activest Wealth Management raised its stake in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on HCA shares. Royal Bank of Canada dropped their price objective on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, January 7th. Finally, Bank of America cut their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $385.67.

Remove Ads

HCA Healthcare Price Performance

NYSE:HCA traded up $3.51 during midday trading on Thursday, hitting $350.54. The company had a trading volume of 479,451 shares, compared to its average volume of 1,346,630. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The stock's fifty day moving average price is $326.35 and its 200-day moving average price is $340.30. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market capitalization of $86.30 billion, a PE ratio of 15.96, a P/E/G ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the company earned $5.90 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a $0.72 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date was Monday, March 17th. HCA Healthcare's payout ratio is 13.11%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.